You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CYTOTEC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cytotec, and what generic alternatives are available?

Cytotec is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in CYTOTEC is misoprostol. There are fourteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the misoprostol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cytotec

A generic version of CYTOTEC was approved as misoprostol by ANI PHARMS on July 10th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CYTOTEC?
  • What are the global sales for CYTOTEC?
  • What is Average Wholesale Price for CYTOTEC?
Summary for CYTOTEC
Drug patent expirations by year for CYTOTEC
Drug Prices for CYTOTEC

See drug prices for CYTOTEC

Recent Clinical Trials for CYTOTEC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityPhase 3
Cairo UniversityN/A
University of Texas at AustinPhase 4

See all CYTOTEC clinical trials

Pharmacology for CYTOTEC

US Patents and Regulatory Information for CYTOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CYTOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CYTOTEC

See the table below for patents covering CYTOTEC around the world.

Country Patent Number Title Estimated Expiration
France 2274289 ⤷  Sign Up
African Intellectual Property Organization (OAPI) 4910 ⤷  Sign Up
Sweden 7503431 ⤷  Sign Up
South Africa 7501391 ⤷  Sign Up
Netherlands 183294 ⤷  Sign Up
Egypt 12063 PROCESS FOR PREPARING OF 16-OXYGENATED PHOSPHANOIC ACID DERIVATIVES ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.